Safety of rosuvastatin: update on 16,876 rosuvastatin-treated patients in a multinational clinical trial program

J Shepherd, DG Vidt, E Miller, S Harris, J Blasetto - Cardiology, 2007 - karger.com
Background: The safety and tolerability of rosuvastatin were assessed using data from
16,876 patients who received rosuvastatin 5–40 mg in a multinational phase II/III/IIIb/IV …
被引用次数：112 相关文章

Safety of Rosuvastatin: Update on 16,876 Rosuvastatin-Treated Patients in a Multinational Clinical Trial Program.

J Shepherd, DG Vidt, E Miller, S Harris… - Cardiology, 2007 - search.ebscohost.com
Background: The safety and tolerability of rosuvastatin were assessed using data from
16,876 patients who received rosuvastatin 5–40 mg in a multinational phase II/III/IIIb/IV …

Safety of Rosuvastatin: Update on 16,876 Rosuvastatin-Treated Patients in a Multinational Clinical Trial Program

J Shepherd, DG Vidt, E Miller, S Harris, J Blasetto - Cardiology, 2007 - search.proquest.com
Safety of Rosuvastatin: Update on 16,876 Rosuvastatin-Treated Patients in a Multinational
Clinical Trial Program Page 1 Fax +41 61 306 12 34 E-Mail karger@karger.ch www.karger.com …

Safety of rosuvastatin: update on 16,876 rosuvastatin-treated patients in a multinational clinical trial program

J Shepherd, DG Vidt, E Miller, S Harris… - Cardiology, 2007 - pubmed.ncbi.nlm.nih.gov
Background The safety and tolerability of rosuvastatin were assessed using data from
16,876 patients who received rosuvastatin 5-40 mg in a multinational phase II/III/IIIb/IV …

Safety of Rosuvastatin: Update on 16,876 Rosuvastatin-Treated Patients in a Multinational Clinical Trial Program

J Shepherd, DG Vidt, E Miller, S Harris, J Blasetto - Cardiology, 2007 - karger.com
Background: The safety and tolerability of rosuvastatin were assessed using data from
16,876 patients who received rosuvastatin 5–40 mg in a multinational phase II/III/IIIb/IV …

Safety of rosuvastatin: update on 16,876 rosuvastatin-treated patients in a multinational clinical trial program.

J Shepherd, DG Vidt, E Miller, S Harris, J Blasetto - Cardiology, 2007 - europepmc.org
Background The safety and tolerability of rosuvastatin were assessed using data from
16,876 patients who received rosuvastatin 5-40 mg in a multinational phase II/III/IIIb/IV …

[引用][C] Safety of Rosuvastatin: Update on 16,876 Rosuvastatin-Treated Patients in a Multinational Clinical Trial Program

J Shepherd, DG Vidt, E Miller, S Harris, J Blasetto - Cardiology, 2007 - cir.nii.ac.jp
Safety of Rosuvastatin: Update on 16,876 Rosuvastatin-Treated Patients in a Multinational
Clinical Trial Program | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] …